Search clinical trials for: Fulvestrant Placebo
Total 54108 results
-
Treadwell Therapeutics, IncRecruitingBreast Cancer | Advanced Solid TumorUnited States
-
Translational Oncology Research InternationalUniversity of California, Los Angeles; AstraZeneca; Genentech, Inc.Terminated
-
Albert Einstein College of MedicineCompletedChronic Kidney DiseaseUnited States
-
iOMEDICO AGNovartis PharmaceuticalsCompletedBreast Cancer | Hormone Receptor Positive Tumor | HER 2 Negative Breast CancerGermany
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingMetastatic Breast Cancer | Advanced Malignancies | Recurrent Breast CancerChina
-
Henan Cancer HospitalJiangsu HengRui Medicine Co., Ltd.Recruiting
-
Guangdong Women and Children HospitalNot yet recruiting
-
Menarini GroupCompletedAdvanced or Metastatic Breast CancerSpain, Belgium, United Kingdom, France, United States, Italy
-
Washington University School of MedicineNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast CancerUnited States
-
ExelixisTerminatedTriple Negative Breast Cancer | Epithelial Ovarian Cancer | Metastatic Castration-resistant Prostate Cancer | Hormone Receptor Positive Breast Carcinoma | Neoplasm MalignantUnited States
-
Cancer Institute and Hospital, Chinese Academy...UnknownHormone Receptor Positive Advanced Breast CancerChina
-
National University Hospital, SingaporeEisai Co., Ltd.Recruiting
-
Mara ChambersNovartisCompleted
-
Borstkanker Onderzoek GroepNovartis Pharma B.V.; BOOG Study CenterRecruitingNeoplasm, Breast | Congenital, Familial and Genetic DisordersNetherlands
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Greater Washington Community FoundationTerminated
-
Novartis PharmaceuticalsCompletedA Study of Inclisiran in Participants With Homozygous Familial Hypercholesterolemia (HoFH) (ORION-5)Homozygous Familial HypercholesterolemiaHong Kong, Israel, Russian Federation, Serbia, South Africa, Taiwan, Turkey, Ukraine
-
Fudan UniversityChongqing University Cancer Hospital; Sun Yat-sen University; Peking University... and other collaboratorsRecruitingBreast Cancer | Advanced Breast Cancer | Breast Neoplasm | HER2-negative Breast Cancer | Hormone Receptor Positive TumorChina
-
Eli Lilly and CompanyCompletedHER-2 Positive Breast Cancer | Hormone Receptor Positive Breast CancerSpain, United States, Korea, Republic of, Belgium, France, Germany, Italy, Australia, Argentina, Canada, United Kingdom, Mexico, Brazil, Greece
-
Queen Mary University of LondonAstraZenecaUnknownEstrogen Receptor Positive Breast CancerSpain, United Kingdom, France, Portugal, Georgia, Korea, Republic of, Germany, Hungary, Romania
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)UnknownRecurrent Uterine Corpus Carcinoma | Stage III Uterine Corpus Cancer AJCC v7 | Stage IV Uterine Corpus Cancer AJCC v7
-
National Taiwan University HospitalRecruitingMetastatic Breast Cancer | Premenopausal Breast Cancer | ER Positive Breast CancerTaiwan
-
Institut CurieRain Oncology IncTerminatedAdvanced or Metastatic Breast CancerFrance
-
Cancer Institute and Hospital, Chinese Academy...OrigiMedUnknown
-
University of Southern CaliforniaAstraZenecaTerminatedBreast CarcinomaUnited States
-
William Beaumont HospitalsTerminatedFibrosis, Liver | Cirrhosis, Liver | Steatohepatitis, Nonalcoholic | Fatty Liver DiseaseUnited States
-
Vanderbilt UniversityMerck Sharp & Dohme LLCWithdrawnPeripheral Artery Disease
-
Contera PharmaBukwang PharmaceuticalActive, not recruitingDyskinesiasFrance, Germany, Italy, Korea, Republic of, Spain
-
University of California, San DiegoTerminated
-
NovartisCompletedAcute Blunt Soft Tissue Injuries/ContusionsUnited States
-
Fengmei LianPeking Union Medical College Hospital; Huashan Hospital; Chengdu University of... and other collaboratorsUnknownDiabetic Peripheral Neuropathy Type 2China
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLCRecruitingMetastatic Breast CancerUnited States
-
Duke UniversityActive, not recruitingMetastatic Breast Cancer | Locally Advanced Breast Cancer | Hormone Receptor Positive TumorUnited States
-
Jazz PharmaceuticalsActive, not recruitingHER2+/HR+ Breast CancerUnited States, Spain, Canada
-
Dana-Farber Cancer InstituteNovartisCompleted
-
Icahn School of Medicine at Mount SinaiAstraZenecaTerminated
-
Fudan UniversityCompletedMetastatic Breast CancerChina
-
Hoffmann-La RocheRecruitingBreast CancerCanada, Belgium, Korea, Republic of, United States, China, Taiwan, Mexico, Brazil, Argentina, Australia, Italy, Spain, Turkey, Thailand, United Kingdom, Poland, South Africa
-
AstraZenecaRecruitingLocally Advanced (Inoperable) or Metastatic Breast CancerSpain, Denmark, United States, Korea, Republic of, Germany, Belgium, Vietnam, United Kingdom, France, Japan, Brazil, Canada, China, India, Malaysia, Taiwan, Thailand, Australia, Turkey, Argentina, Poland, Sweden, Italy
-
Eisai Co., Ltd.Active, not recruiting
-
Nancy Chan, MDMerck Sharp & Dohme LLCActive, not recruiting
-
ISU Abxis Co., Ltd.UnknownAcute Myocardial InfarctionKorea, Republic of
-
Bristol-Myers SquibbCompleted
-
Smartfish ASCompletedCachexia | COPDSweden
-
Smartfish ASCompletedNSCLC | CachexiaItaly, Sweden, Croatia, Slovakia
-
Kuopio University HospitalWithdrawnAtrial FibrillationFinland
-
Marina N SharifiNovartis; University of Wisconsin, MadisonRecruitingHormone Receptor Positive Breast Carcinoma | HER2-negative Breast Cancer | PIK3CA Mutant Metastatic Breast CancerUnited States
-
Beta Pharma (Suzhou) Co., Ltd.RecruitingAdvanced Solid Tumor | HR+/HER2- Breast CancerChina
-
Spanish Breast Cancer Research GroupAstraZenecaTerminated
-
Calithera Biosciences, IncCompleted